TRIP13 predicts poor prognosis in clear cell renal cell carcinoma.
Adam Kowalewski, Damian Jaworski, Paulina Antosik, Marta Smolińska, Joanna Ligmanowska, Dariusz Grzanka, Łukasz Szylberg
Abstract
< 0.05). TRIP13 overexpression predicts poor prognosis in ccRCC. Together with the emerging reports, this observation raises a suspicion that TRIP13 is a substantial driver of resistance to systemic therapies against kidney cancer.
Topics & Concepts
MedicineClear cell renal cell carcinomaTissue microarrayProportional hazards modelRenal cell carcinomaOncologyHazard ratioInternal medicineKidney cancerImmunohistochemistryCancer researchConfidence intervalRenal cell carcinoma treatmentCancer Genomics and DiagnosticsRenal and related cancers